Abramovitz, Melissa. Parkinson's Disease. San Diego, CA: Thomson/Gale, 2005. Print.
Goldmann, David R., and David A. Horowitz. American College of Physicians Home Medical Guide to Parkinson's Disease. New York: Dorling Kindersley Pub., 2000. Print.
Mandal, Ananya. "Parkinson's Disease History." News-Medical.net. N.p., 2013. Web. 08 Oct. 2016.
ParkinsonDotOrg. "National Parkinson Foundation: Believe in Better." National Parkinson Foundation. N.p., n.d. Web. 02 Oct. 2016.Biology Research Paper: Parkinson’s Disease
Parkinson's Disease is a mysterious disease that affects the central nervous system and can be very difficult to treat and live with. It is classified as a motor system disorder but is a progressive, chronic disease resulting in
…show more content…
on the account of ancient Indian texts relating to the Ayurveda medical system which identified the disease as Kampavata. Many others have identified Parkinson’s throughout time as either the “shaking palsy” or its Latin form “paralysis agitans” (Abramovitz, 10). People such as Middle Age physician Galen in 175 AD and widely known Leonardo Da Vinci all picked up on the presence of Parkinson’s Disease before it’s official description was written in 1817 in …show more content…
Unfortunately, no treatment has been able to fully cure the disease. Treatment began primitively, consisting of things such as “bloodletting from the neck” which was followed by induced inflammation and blistering to the skin. Today, the most common and effective way of treating Parkinson’s temporarily is through attempting to balance dopamine and acetylcholine levels within the brain by prescribing patients with what is known on the market commonly as Levodopa. It is essentially a dopamine supplement of which’s dosage must be individualized for each different patient since the symptoms vary from person to person (Goldmann, 44). This treatment will eventually become less and less effective as the progression of the disease continues. All that patients and neurologists seem to be able to do is attempt to manage the symptoms it
Parkinson’s disease is not a condition that is necessarily easy to be diagnosed. Therefore, the individual is advised to see a Parkinson’s specialist to receive the most accurate diagnosis and consider what the best course of treatment for the individual would be.
Web. The Web. The Web. 02 Oct. 2013. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259136/>. Vision:
Many people, like myself, after watching an episode of “The Michael Jay Fox Show,” started to be come curious as to what exactly this disease is. You ask yourself; What is this disease? What causes it? Can it be passed down from generation to generation? Is there a treatment? What would your life be like suffering from this? Through my research on Parkinson’s disease, I am determined to answer these questions. I hope to have a better understanding on this disease, and how it affects the lives of patients that I might see in a hospital.
Salgado, S., Williams, N., Kotian, R., & Salgado, M. (2013). An Evidence-Based Exercise Regimen for Patients with Mild to Moderate Parkinson's Disease. Brain Sciences (2076-3425), 3(1), 87-100.
With more than 200,000 US cases per year, Parkinson’s disease has become a major part
Magennis, B. & Corry, M. (2013). Parkinson’s disease: Making the diagnosis and monitoring progression. British Journal of Neuroscience Nursing, 9(4), 167-171. Retrieved from 20 November 2013, http://ehis.ebscohost.com.libproxy.nyp.edu.sg/ehost/pdfviewer/pdfviewer?sid=7ff72265-6870-4b18-adff-ce7460be5bc2%40sessionmgr10&vid=4&hid=2
Parkinson's is an idiopathic, multifactorial neurodegenerative disease that attacks neurotransmitters in the brain called dopamine. Dopamine is concentrated in a specific area of the brain called the substantia nigra. The neurotransmitter dopamine is a chemical that regulates muscle movement and emotion. Dopamine is responsible for relaying messages between the substantia nigra and other parts of the brain to control body movement. The death of these neurotransmitters affects the central nervous system. The most common symptoms are movement related, including shaking, rigidity, slowness of movement and difficulty with posture. Behavioral problems may arise as the disease progresses. Due to the loss of dopamine, Parkinson's patients will often experience depression and some compulsive behavior. In advanced stages of the disease dementia will sometimes occur. The implications of the disease on the anatomy and physiology of the respiratory and phonatory systems significantly control speech.
Parkinson’s disease is a chronic, progressive neurodegenerative disorder characterised by resting tremor, slowed movements, rigidity and postural instability (Casey G, 2013). It is the second most common neurodegenerative disorder after Alzheimer’s (Martin and Mills, 2012). There is a great variability in reported incidence rates, probably due to difference in diagnostic criteria and case ascertainment, with reported rates in Australia and in Western countries ranging from 8.6 to 19.0 per 100,000 population (J Macphee and D Stewart, 2012). The two main brain structures affected by Parkinson’s are the substantia nigra pars compacta, which is located in the midbrain and other parts of the basal ganglia, w...
Pubmed Health. 2010 - November 17th, 2010. Retrieved January 9, 2012, from Pubmed Health. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002390/. Rumford, S. (2001).
Langston, J. W. "Current Theories on the Cause of Parkinson’s Disease. " Journal of Neurology, Neurosurgery, and Psychiatry. 1989, suppl. ,pp. 13-i7.
The path physiology of Parkinson’s disease is the pathogenesis if Parkinson disease is unknown. Epidemiologic data suggest genetic, viral, and environmental toxins as possible causes. Nigral and basal loss of neurons with depletion of dopamine, an inhibitory neurotransmitter, is the principal biochemical alteration in Parkinson disease. Symptoms in basal ganglia disorders result from an imbalance of dopaminergic (inhibitory) and cholinergic (excitatory) activity in the caudate and putamen of the basal ganglia.
Thomas, C. G. (2013, November 25). National Institute of Neurological Disorders and Stroke. Gene-silencing study finds new targets for Parkinson's disease, pp. 1-2. Retrieved December 13, 2013, from http://www.nih.gov/news/health/nov2013/ninds-24.htm
James Parkinson first discovered Parkinson's Disease in 1817. Parkinson's Disease is a common neurologic disorder for the elderly. It is a disorder of the brain characterized by shaking and difficulty with walking, movement, and coordination. This disease is associated with damage to a part of the brain that controls muscle movement. Parkinson's Disease is a chronic illness that is still being extensively studied.
"Secondary Parkinsonism: MedlinePlus Medical Encyclopedia." U.S National Library of Medicine. U.S. National Library of Medicine, n.d. Web. 11 May 2014.
Web. The Web. The Web. 04 Dec. 2013. http://www.ncbi.nlm.nih.gov/pubmed/21663987